Dr. Reddy’s Laboratories rises on launching Pregabalin Capsules in US Market

31 Jul 2019 Evaluate

Dr. Reddy's Laboratories is currently trading at Rs. 2574.75, up by 12.70 points or 0.50% from its previous closing of Rs. 2562.05 on the BSE.

The scrip opened at Rs. 2550.00 and has touched a high and low of Rs. 2590.00 and Rs. 2520.65 respectively. So far 13137 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2965.20 on 02-May-2019 and a 52 week low of Rs. 2065.00 on 31-Jul-2018.

Last one week high and low of the scrip stood at Rs. 2725.00 and Rs. 2520.65 respectively. The current market cap of the company is Rs. 42977.80 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 44.50% and 14.44% respectively.

Dr. Reddy’s Laboratories has launched Pregabalin Capsules a therapeutic equivalent generic version of Lyrica (pregabalin) capsules approved by the U.S. Food and Drug Administration (USFDA). The Lyrica (pregabalin) Capsules brand had U.S. sales of approximately $5,462 million MAT for the most recent twelve months ending in May 2019 according to IQVIA Health.

The company’s Pregabalin Capsules are available in 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg capsules in bottle count sizes of 90. This is also a controlled substance schedule V product. Lyrica is a trademark of C.P. Pharmaceuticals International C.V.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×